ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.599,57
-0,46%
S&P 500
5.222,68
0,16%
US Dollar vs BRL
5,1559
0,18%
Bitcoin
62.690,81
2,02%
Brent Oil
82,99
0,73%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Tiziana Life Sciences Ltd (TLSA)

  7. Tiziana Life Sciences Ltd (TLSA) Notícias

TLSA

Tiziana Life Sciences (TLSA)

Tiziana Life Sciences Ltd
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:TLSA
DataHoraFonteTítuloCódigoCompanhia
10/05/202418:00Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:TLSATiziana Life Sciences Ltd
05/03/202409:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TLSATiziana Life Sciences Ltd
01/09/202318:16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TLSATiziana Life Sciences Ltd
15/08/202311:25AllPennyStocks.comBiotech Shares Experience Massive Premarket Buying PressureNASDAQ:TLSATiziana Life Sciences Ltd
13/06/202311:29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLSATiziana Life Sciences Ltd
26/04/202315:37Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:TLSATiziana Life Sciences Ltd
13/04/202308:04InvestorsHub NewsWireTiziana Life Sciences to Pursue Development of Intranasal Foralumab for the Treatment of Long COVIDNASDAQ:TLSATiziana Life Sciences Ltd
31/03/202308:07InvestorsHub NewsWireTiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders ConferenceNASDAQ:TLSATiziana Life Sciences Ltd
27/12/202219:00GlobeNewswire Inc.Tiziana Life Sciences Ltd (“Tiziana” or “the Company”) - Interim Results for the Six Months Ended 30 June 2022NASDAQ:TLSATiziana Life Sciences Ltd
19/10/202208:00GlobeNewswire Inc.Tiziana Life Sciences Ltd Invites You to Join Us at The ThinkEquity ConferenceNASDAQ:TLSATiziana Life Sciences Ltd
12/10/202211:05AllPennyStocks.comBiotech Sees Premarket Buying Pressure Following IND ApplicationNASDAQ:TLSATiziana Life Sciences Ltd
21/09/202210:40TipRanksWall Street Analysts Are Bullish on Top Healthcare PicksNASDAQ:TLSATiziana Life Sciences Ltd
16/06/202213:36TipRanksB.Riley Financial Thinks Tiziana Life Sciences’ Stock is Going to RecoverNASDAQ:TLSATiziana Life Sciences Ltd
09/06/202213:25GlobeNewswire Inc.Tiziana Life Sciences Announces An Interview on Clinical Improvements for 2nd SPMS PatientNASDAQ:TLSATiziana Life Sciences Ltd
04/05/202217:35Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TLSATiziana Life Sciences Ltd
29/04/202217:14Edgar (US Regulatory)Notification That Form 20-f Will Be Submitted Late (nt 20-f)NASDAQ:TLSATiziana Life Sciences Ltd
06/04/202210:45TipRanksB.Riley Financial Sticks to Their Buy Rating for Tiziana Life Sciences (TLSA)NASDAQ:TLSATiziana Life Sciences Ltd
11/03/202206:04TipRanksAnalysts Are Bullish on These Healthcare Stocks: Tiziana Life Sciences (TLSA)NASDAQ:TLSATiziana Life Sciences Ltd
10/03/202212:55TipRanksB.Riley Financial Keeps Their Buy Rating on Tiziana Life Sciences (TLSA)NASDAQ:TLSATiziana Life Sciences Ltd
04/03/202209:00GlobeNewswire Inc.AccuStem Sciences, Inc. Appoints New Executive Leadership TeamNASDAQ:TLSATiziana Life Sciences Ltd
25/02/202218:14Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3/a)NASDAQ:TLSATiziana Life Sciences Ltd
19/01/202211:08InvestorsHub NewsWireALYI - Underestimating The Potential Of Alternet Systems Could Be The Investment Blunder Of 2022...Here's WhyNASDAQ:TLSATiziana Life Sciences Ltd
21/10/202103:00GlobeNewswire Inc.Share Capital Consolidation and Commencement of trading in the New Tiziana Shares on NASDAQNASDAQ:TLSATiziana Life Sciences Ltd
20/10/202117:09Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:TLSATiziana Life Sciences Ltd
20/10/202110:40GlobeNewswire Inc.Tiziana Life Sciences - Scheme Effective DateNASDAQ:TLSATiziana Life Sciences Ltd
20/10/202103:00GlobeNewswire Inc.Tiziana Life Sciences plc: PDMR DealingNASDAQ:TLSATiziana Life Sciences Ltd
19/10/202110:26GlobeNewswire Inc.Tiziana Life Sciences plc: Court Sanctions the Scheme of Arrangement and approves Reduction of CapitalNASDAQ:TLSATiziana Life Sciences Ltd
27/09/202113:39GlobeNewswire Inc.Tiziana Life Sciences Plc - Results of Court Meeting and General MeetingNASDAQ:TLSATiziana Life Sciences Ltd
24/09/202113:51GlobeNewswire Inc.Tiziana Life Sciences plc - Interim Results for the Six Months Ended 30 June 2021NASDAQ:TLSATiziana Life Sciences Ltd
07/09/202103:00GlobeNewswire Inc.Tiziana to Host Investor Call to Discuss Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer TreatmentNASDAQ:TLSATiziana Life Sciences Ltd
 Apresentando as notícias mais relevantes sobre:NASDAQ:TLSA

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
COGN3
COGNA ON
BOV
BHIA3
Grupo Casas Bahia ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados